A controlled trial of naproxen sodium for relief of pain associated with Vabra suction curettage

  1. N. C. SIDDLE Lecturer and Senior Registrar1,
  2. O. YOUNG Research Sister1,
  3. C. M. SLEDMERE Research Assistant2,
  4. A. E. READING Senior Clinical Psychologist2,†,
  5. M. I. WHITEHEAD Senior Lecturer and Consultant Gynaecologist1

Article first published online: 23 AUG 2005

DOI: 10.1111/j.1471-0528.1983.tb09329.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 90, Issue 9, pages 864–869, September 1983

Additional Information

How to Cite

SIDDLE, N. C., YOUNG, O., SLEDMERE, C. M., READING, A. E. and WHITEHEAD, M. I. (1983), A controlled trial of naproxen sodium for relief of pain associated with Vabra suction curettage. BJOG: An International Journal of Obstetrics & Gynaecology, 90: 864–869. doi: 10.1111/j.1471-0528.1983.tb09329.x

Author Information

  1. 1

    Menopause Unit, Academic Department of Obstetrics and Gynaecology, Kings College Hospital Medical School, Denmark Hill, London SE5 8RX

  2. 2

    Department of Psychology, Kings College Hospital Medical School, Denmark Hill, London SE5 8RX

  1. †

    University of California School of Medicine, Center for the Health Sciences, 760 Westwood Plaza. Los Angeles. California 900024. USA.

Publication History

  1. Issue published online: 23 AUG 2005
  2. Article first published online: 23 AUG 2005
  3. Received 23 August 1982 Accepted 10 February 1983

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (408K)

Summary. In a double-blind study naproxen sodium (550 mg), or placebo was administered 1 h before Vabra curettage and pain associated with the procedure was assessed immediately after operation and 30, 60 and 120 min later by visual analogue and verbal rating scales, and the McGill pain questionnaire. The pre-curettage anxiety of the patients was assessed by the Spielberger state anxiety inventory. Of the 58 patients, 51 (87.9%) reported pain during the procedure; there was no relation between the level of pain experienced and the pre-curettage anxiety score. Compared with the placebo group, the pain experienced by the naproxen group was significantly less as measured by the McGill pain questionnaire immediately after curettage, and by visual analogue scales 30 and 60 min after the procedure. The verbal rating scales showed that naproxen significantly reduced backache 30 min after curettage, and cramp immediately after the procedure and 30 and 60 min later but did not reduce the severity of the pain associated with the procedure.

Get PDF (408K)